Business briefs: Amgen Inc. downsizing

The biotechnology company, Amgen Inc., plans to cut up to 14 percent of its work force. The Thousand Oaks-based firm said it plans to reduce its work force by 12 percent to 14 percent, or between 2,200 and 2,600 positions, and take with a restructuring charge between $600 million and $700 million. Amgen (AMGN) also lowered its profit guidance because of slimmer-than-expected sales of its anemia drug.

PENNIES

Rising metal prices have prompted lawmakers to consider dropping the zinc from pennies. Jarden Zinc Products (JAH), the government’s sole supplier of “penny blanks,” previously fought legislation allowing retailers to round off cash transactions, effectively eliminating the penny. The company has said it would be willing to consider producing blanks in other metals.

Just Posted

DA elect joins Breed to denounce attacks against Chinatown seniors

Days after three seniors were brutally attacked on video at a popular… Continue reading

SF takes ‘next step’ to become first in California to launch public bank

City officials plan to cut ties with Wall Street banks

Mayor, supervisors reach consensus on plan to fix SF’s mental health system

Both parties agree to drop ballot measures and pursue reform with legislation.

Hate crimes jump 58 percent in San Francisco, FBI report shows

While numbers fall slightly in California, The City records an increase

Treasure Island residents could get a break on tolls

New proposal would exempt current occupants from congestion pricing for at least six years

Most Read